Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted delivery of drugs to the myometrium via polypeptides that bind to the oxytocin receptor

Targeted delivery of drugs to the myometrium via polypeptides that bind to the oxytocin receptor

US Patent 10952964 · Granted Mar 23, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2024
Protein-polymer-drug conjugates2022
Markers of tissue aging and uses therefor2022
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2021
Controlling airloads on aircraft folding wing tips2021
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/2021
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2020
Pyrimido-pyridazinone compounds and methods of use thereof2020
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cance2019
Targeted delivery of drugs to the myometrium via anti-oxytocin receptor antibodi2019
Targeted delivery of drugs to the myometrium via anti-oxytocin receptor antibodi2019
Targeted delivery of drugs to the myometrium via anti-oxytocin receptor antibodi2019